Morgan Stanley Institutional Fund, Inc. Inception Portfolio Class C MSCOX

Medalist Rating as of | See Morgan Stanley Investment Hub
  • NAV / 1-Day Return 10.30  /  −0.29 %
  • Total Assets 221.9M
  • Adj. Expense Ratio
    2.100%
  • Expense Ratio 2.100%
  • Distribution Fee Level Above Average
  • Share Class Type Level Load
  • Category Small Growth
  • Investment Style Small Blend
  • Min. Initial Investment 1,000
  • Status Open
  • TTM Yield 0.00
  • Turnover 97%

USD | NAV as of Oct 02, 2026 | 1-Day Return as of Oct 02, 2026, 12:11 AM GMT+0

Morningstar’s Analysis MSCOX

Will MSCOX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

Morgan Stanley Inst Inception C holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings MSCOX

  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 55.4
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Agilon Health Inc

9.08 26M
Healthcare

Cloudflare Inc

8.93 25M
Technology

Opendoor Technologies Inc Ordinary Shares - Class A

7.37 21M
Real Estate

Aurora Innovation Inc Class A

6.56 19M
Consumer Cyclical

IonQ Inc

5.86 17M
Technology

X4 Pharmaceuticals Inc

3.81 11M
Healthcare

HealthEquity Inc

3.60 10M
Healthcare

Celsius Holdings Inc

3.53 10M
Consumer Defensive

Immunovant Inc

3.43 10M
Healthcare

GRAIL Inc

3.19 9M
Healthcare

Sponsor Center